India's largest private sector lender, HDFC Bank, witnessed a sharp decline of nearly 5% in its share price on Monday after announcing its Q1FY27 financial results. While the bank reported steady profit growth and robust business expansion.
India's pharmaceutical industry is witnessing a significant shift in executive compensation, with performance-linked remuneration becoming the preferred model for rewarding top leadership.
India's pharmaceutical industry is entering a new growth phase as the domestic market for GLP-1 (Glucagon-Like Peptide-1) medicines gains momentum. These drugs, led by semaglutide.
Indian equity markets began Monday's trading session on a weak footing as investors reacted to escalating geopolitical tensions in the Middle East and a sharp jump in international crude oil prices.
The Government of India has unveiled the draft Corporate Average Fuel Efficiency (CAFE)-III norms, proposing a comprehensive overhaul of the country's fuel-efficiency framework for passenger vehicles.
In a major advancement for India's healthcare sector, Novo Nordisk India has received approval from the Central Drugs Standard Control Organisation (CDSCO) for a new indication of its blockbuster medicine Wegovy.
Gold prices remained under pressure in global markets as investors weighed the impact of escalating geopolitical tensions in West Asia against growing expectations that the US Federal Reserve could keep interest rates higher for longer.
The Competition Commission of India (CCI) has dismissed a complaint alleging anti-competitive practices against Reliance Jio Infocomm Ltd and more than 4,500 companies operating across multiple industries.
Global crude oil markets have once again entered a period of heightened uncertainty as renewed geopolitical tensions surrounding the Strait of Hormuz reignite fears of supply disruptions. After briefly stabilizing earlier this year.